Publications of Peter J. Murray

Journal Article (43)

41.
Journal Article
Murray, P. J.: Immune regulation by monocytes. Seminars in Immunology 35, pp. 12 - 18 (2018)
42.
Journal Article
Zeng, Q.; Fu, J.; Korrer, M.; Gorbounov, M.; Murray, P. J.; Pardoll, D.; Masica, D. L.; Kim, Y. J.: Caspase-1 from Human Myeloid-Derived Suppressor Cells Can Promote T Cell-Independent Tumor Proliferation. Cancer Immunology Research 6 (5), pp. 566 - 577 (2018)
43.
Journal Article
Steggerda, S. M.; Bennett, M. K.; Chen, J.; Emberley, E.; Huang, T.; Janes, J. R.; Li, W.; MacKinnon, A. L.; Makkouk, A.; Marguier, G. et al.; Murray, P. J.; Neou, S.; Pan, A.; Parlati, F.; Rodriguez, M. L. M.; Van de Velde, L.-A.; Wang, T.; Works, M.; Zhang, J.; Zhang, W.; Gross, M. I.: Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment. Journal for ImmunoTherapy of Cancer 5, 101 (2017)

Conference Paper (1)

44.
Conference Paper
Carolin, K.; Fundel-Clemens, K.; Schloesser, D.; Lerner, C.; Frey, S.; Wohnhaas, C. T.; Viollet, C.; Dichtl, S.; Tilp, C.; Thomas, M. J. et al.; Gantner, F.; Skronska-Wasek, W.; Huber, H. J.; Murray, P. J.; Ramirez, F.; El Kasmi, K. C.: LSC-2021-The Anti-Fibrotic Drug Nintedanib Promotes Repair Macrophages. 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”. European Respiratory Journal 58 (Suppl. 65), OA4335, (2021)

Meeting Abstract (3)

45.
Meeting Abstract
Baumann, T.; Dunkel, A.; Schmid, C.; Schmitt, S.; Hiltensperger, M.; Laketa, V.; Donakonda, S.; Ahting, U.; Lorenz-Depiereux, B.; Heil, J. et al.; Schredelseker, J.; Simeoni, L.; Heine, A.; Fechner, C.; Schraven, B.; Spiegel, D.; Misgeld, T.; Zischka, H.; Murray, P.; Korn, T.; Dawid, C.; Hofmann, T.; Knolle, P.; Hoechst, B.: Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal. In Oncology Research and Treatment, 44 (S4), V753, p. 84 - 84. Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (Hybrid-Kongress), October 01, 2021 - October 04, 2021. Karger, Basel (2021)
46.
Meeting Abstract
Peng, W.; Merlo, L. M. F.; DuHadaway, J. B.; Montgomery, J. D.; Murray, P. J.; Yeh, S.-R.; Prendergast, G. C.; Muller, A. J.; Mandik-Nayak, L.: A distinct non-enzymatic role for Indoleamine-2,3-dioxygenase (IDO)2 vs. IDO1 in autoimmune arthritis. In The Journal of Immunology, 206 (Suppl.), 63.02. Williams & Wilkins, Baltimore, U.S.A. (2021)
47.
Meeting Abstract
Senz, A. M.; Metzger, P.; Rubens, R. K.; Cadilha, B.; Kirmaier, M.; Lesch, S.; Benmebarek, M. R.; Theurich, S.; Murray, P.; Endres, S. et al.; Kobold, S.; Koenig, L. M.; Duewell, P.; Schnurr, M.: IDO1-deleted CAR T cells show improved therapeutic efficacy in murine pancreatic cancer models. In Journal for ImmunoTherapy of Cancer, 8, p. A43 - A43. BMJ PUBLISHING GROUP, BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND (2020)
Go to Editor View